logoTry Persana

Promakhos Therapeutics - Company Overview, Founder, CEO, Funding & Investment Details

Complete information about Promakhos Therapeutics including founder details, CEO information, total funding raised, headquarters location, team size, and recent investment rounds.

Promakhos Therapeutics company logo

Creating transformative medicines for patients with inflammatory diseases.

Developing transformative medicines for patients with inflammatory diseases.

HeadquartersBoston, United States
Team size1-10
Founded2021

What is Promakhos Therapeutics? - Company Overview & Details

Promakhos Therapeutics is Developing transformative medicines for patients with inflammatory diseases. Founded in 2021, the company is headquartered in Boston, United States.

Who are the Key Executives at Promakhos Therapeutics? - Leadership Team

Promakhos Therapeutics is led by experienced executives in key positions:

Chief Executive Officer (CEO) of Promakhos Therapeutics

CEO

Chief Technology Officer (CTO) of Promakhos Therapeutics

CTO

Promakhos Therapeutics Company Details & Key Information

Where is Promakhos Therapeutics located?

Promakhos Therapeutics is headquartered in Boston, United States.

How many employees does Promakhos Therapeutics have?

Promakhos Therapeutics has 1-10 employees.

When was Promakhos Therapeutics founded?

Promakhos Therapeutics was founded in 2021.

Promakhos Therapeutics Official Website

How much funding has Promakhos Therapeutics raised?

Promakhos Therapeutics has raised undisclosed amount across 3 funding rounds. The most recent funding was completed on 2021-10-02.

Funding Overview

Promakhos Therapeutics has completed 3 funding rounds since its inception.

N/A
Total Funding Raised
3
Funding Rounds
2021-10-02
Latest Round

Promakhos Therapeutics Funding History

Seed
2021-10-02

Who are the key investors in Promakhos Therapeutics?

Investor Information Not Available

Detailed information about Promakhos Therapeutics investors is not currently available in our database.

What are Promakhos Therapeutics's future plans?

Promakhos Therapeutics Continue to advance their innovative immunotherapy.

Promakhos Therapeutics Strategic Outlook

Strategic Focus
Defined
0
Key Challenges
0
Growth Opportunities

What are the latest news about Promakhos Therapeutics?

Promakhos Therapeutics has 2 recent news updates covering key business developments and market activities.

Promakhos Therapeutics News Overview

2
Recent Articles
Active
Media Coverage
2025-02-12
Latest Update

What is Promakhos Therapeutics in the news for?

Promakhos Therapeutics is currently featured in news for Promakhos Therapeutics Receives Support from Propel a Cure and other significant business developments.

Recent News Articles About Promakhos Therapeutics

Article 1
2025-02-12

Promakhos Therapeutics Receives Support from Propel a Cure

Promakhos Therapeutics expresses gratitude for support in their efforts to advance immunotherapy for inflammatory diseases.

Article 2
2025-03-16

Looking for a Medicinal Chemist

Promakhos is hiring a medicinal chemist to push forward their immunotherapy project.

Promakhos Therapeutics FAQ - Frequently Asked Questions About Founder, CEO, Funding & Company Details

Find answers to the most common questions about Promakhos Therapeutics including information about founders, CEO, funding history, investors, headquarters location, and company details. 9 frequently asked questions covering key information about the company.

Promakhos Therapeutics Questions & Answers - Company Information

Q1

What is Promakhos Therapeutics?

Developing transformative medicines for patients with inflammatory diseases.

Q2

Where is Promakhos Therapeutics headquartered?

Promakhos Therapeutics is headquartered in Boston, United States.

Q3

When was Promakhos Therapeutics founded?

Promakhos Therapeutics was founded in 2021.

Q4

How many employees does Promakhos Therapeutics have?

Promakhos Therapeutics has 1-10 employees.

Q5

What is Promakhos Therapeutics's official website?

You can visit Promakhos Therapeutics's official website at https://www.promakhos.com.

Q6

What was Promakhos Therapeutics's latest funding round?

Promakhos Therapeutics's latest funding round was a Seed round completed on 2021-10-02.

Q7

What does the company do?

Developing transformative medicines for patients with inflammatory diseases.

Q8

Latest funding date?

2021-10-02

Q9

Latest news?

Promakhos Therapeutics expresses gratitude for support in their efforts to advance immunotherapy for inflammatory diseases. Promakhos is hiring a medicinal chemist to push forward their immunotherapy project.

More Information About Promakhos Therapeutics

For additional details about Promakhos Therapeutics, including the latest news, funding updates, and company developments, explore our comprehensive company database. Find information about startup funding, company valuations, executive leadership, and business intelligence data.